REVIEW article

Front. Pediatr.

Sec. Neonatology

Volume 13 - 2025 | doi: 10.3389/fped.2025.1521668

This article is part of the Research TopicBronchopulmonary Dysplasia: Latest Advances-Volume IIView all 9 articles

Advancements in Biomarkers and Machine Learning for Predicting of Bronchopulmonary Dysplasia and Neonatal Respiratory Distress Syndrome in Preterm Infants

Provisionally accepted
Seyedehelham  ShamsSeyedehelham Shams1Reza  BahramiReza Bahrami2*Seyed Alireza  DastgheibSeyed Alireza Dastgheib2Maryam  YeganegiMaryam Yeganegi3Sepideh  AziziSepideh Azizi4Mahsa  DanaieMahsa Danaie4Mohammad  Golshan-TaftiMohammad Golshan-Tafti5Ali  MasoudiAli Masoudi6Amirhossein  ShahbaziAmirhossein Shahbazi7Amirmasoud  ShiriAmirmasoud Shiri2Kazem  AghiliKazem Aghili6Mahmood  NoorishadkamMahmood Noorishadkam6Hossein  NeamatzadehHossein Neamatzadeh6
  • 1Hamadan University of Medical Sciences, Hamedan, Hamadan, Iran
  • 2Shiraz University of Medical Sciences, Shiraz, Iran
  • 3Iranshahr University of Medical Sciences, Iranshahr, Sistan and Baluchestan, Iran
  • 4Iran University of Medical Sciences, Tehran, Tehran, Iran
  • 5Islamic Azad University, Yazd, Yazd, Yazd, Iran
  • 6Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Yazd, Iran
  • 7Medical University of Ilam, Ilam, Ilam, Iran

The final, formatted version of the article will be published soon.

Recent advancements in biomarker identification and machine learning have significantly enhanced the prediction and diagnosis of Bronchopulmonary Dysplasia (BPD) and neonatal respiratory distress syndrome (nRDS) in preterm infants. Key predictors of BPD severity include elevated cytokines like Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α), as well as inflammatory markers such as the Neutrophil-to-Lymphocyte Ratio (NLR) and soluble gp130. Research into endoplasmic reticulum stress-related genes, differentially expressed genes, and ferroptosis-related genes provides valuable insights into BPD's pathophysiology. Machine learning models like XGBoost and Random Forest have identified important biomarkers, including CYYR1, GALNT14, and OLAH, improving diagnostic accuracy. Additionally, a five-gene transcriptomic signature shows promise for early identification of at-risk neonates, underscoring the significance of immune response factors in BPD. For nRDS, biomarkers such as the lecithin/sphingomyelin (L/S) ratio and oxidative stress indicators have been effectively used in innovative diagnostic methods, including attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and high-content screening for ABCA3 modulation. Machine learning algorithms like Partial Least Squares Regression (PLSR) and C5.0 have shown potential in accurately identifying critical health indicators. Furthermore, advanced feature extraction methods for analyzing neonatal cry signals offer a non-invasive means to differentiate between conditions like sepsis and nRDS. Overall, these findings emphasize the importance of combining biomarker analysis with advanced computational techniques to improve clinical decision-making and intervention strategies for managing BPD and nRDS in vulnerable preterm infants.

Keywords: biomarkers, Bronchopulmonary Dysplasia, neonatal respiratory distress syndrome, machine learning, predictive models, preterm infants

Received: 02 Nov 2024; Accepted: 04 Feb 2025.

Copyright: © 2025 Shams, Bahrami, Dastgheib, Yeganegi, Azizi, Danaie, Golshan-Tafti, Masoudi, Shahbazi, Shiri, Aghili, Noorishadkam and Neamatzadeh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Reza Bahrami, Shiraz University of Medical Sciences, Shiraz, Iran

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more